A Pilot Feasibility Study to Evaluate the Efficacy of Lapatinib in Eliminating Cytokeratin-Positive Tumour Cells Circulating in the Blood of Women With Breast Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lapatinib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
Most Recent Events
- 28 Sep 2015 Biomarkers information updated
- 13 Jun 2012 Actual end date Nov 2011 added as reported by ClinicalTrials.gov.
- 13 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.